Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Menu
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Psychedelics
Disclosures
Featured news in
The Life Sciences Report
ProMIS Neurosciences Inc.
(PMN:TSX; PMN:NCM)
ProMIS Neurosciences Adds Pharmaceutical Leader Timothy Rothwell to Board of Advisors (2/21/2019)
view
DURECT Corp.
(DRRX:NASDAQ)
DURECT Corporation to Participate in the Berenberg NASH Day (2/21/2019)
view
Celgene Corp.
(CELG:NASDAQ)
Agios' Tibsovo Gets FDA Priority Review in First-Line Cancer (2/21/2019)
view
Mesoblast Ltd.
(MESO:NASDAQ; MSB:ASX)
Mesoblast Reports Financial Results and Operational Highlights for the First Half Ended December 31, 2018 (2/20/2019)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
BrainStorm to Present at 2019 Sachs Associates European Life Sciences CEO Forum in Zurich, Switzerland (2/21/2019)
view
Sproutly Canada Inc.
(SPR:CSE; SRUTF:OTCQB)
Leadership Changes to Help Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) Become a Leading Cannabis Formulation Company (2/19/2019)
view
Global Compliance Applications Corp.
(APP:CSE; FUAPF:OTCQB; 2FA:FSA)
Streetwise Reports Examines Company Bringing Advanced Technology to the Cannabis Space (2/20/2019)
view
Avivagen Inc.
(VIV:TSX.V; VIVXF:OTCQB)
Avivagen enters into Partnership with CSA to Sell and Distribute OxC-beta(TM) Livestock in the United States (2/20/2019)
view
Celgene Corp.
(CELG:NASDAQ)
Ultragenyx (RARE) Posts Narrower-Than-Expected Loss in Q4 (2/20/2019)
view
Celgene Corp.
(CELG:NASDAQ)
How to Replicate Hedge Fund Strategies with ETFs (2/19/2019)
view
Celgene Corp.
(CELG:NASDAQ)
Intercept Pharmaceuticals (ICPT) Surges: Stock Moves 6.1% Higher (2/20/2019)
view
Global Compliance Applications Corp.
(APP:CSE; FUAPF:OTCQB; 2FA:FSA)
Los Angeles Based Downtown Meds to Use and Resell Citizen Green Technology (2/19/2019)
view
Mesoblast Ltd.
(MESO:NASDAQ; MSB:ASX)
Final Patient Dosed in Mesoblast Phase 3 Trial of Revascor Cell Therapy for Advanced Heart Failure (2/19/2019)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
BrainStorm Issues a Statement to Patients and Shareholders (2/19/2019)
view